Clinical trial
"Salvage Use" of Recombinant Factor VIIa After Inadequate Haemostasis in Complex…
NCT00214656 · Austin Health, Other · Unknown status
Key facts
| NCT number | NCT00214656 |
|---|---|
| Title | "Salvage Use" of Recombinant Factor VIIa After Inadequate Haemostasis in Complex Cardiac Surgery |
| Official title | "Salvage Use" of Recombinant Activated Factor VII After Inadequate Haemostatic Response to Conventional Therapy in Complex Cardiac Surgery - a Randomised Placebo Controlled Trial |
| Lead sponsor | Austin Health, Other |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Myocardial Ischemia, Blood Coagulation Disorders, Coronary Artery Disease, Heart Valve Diseases |
| Intervention type | Drug |
| Interventions | Recombinant Activated Factor VII |
| Enrollment | 40 |
| Start date | Jun 1, 2005 |
| Completion | Jun 1, 2008 |
| First posted | Sep 22, 2005 |
| Last update posted | Sep 22, 2005 |
| Countries | Australia |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: